Bio Search Co., Ltd. agreed to acquire InnerEye Ltd. through a share exchange agreement. The Tokyo-based company develops biometric sensing devices, medical equipment, and a data analysis platform. The deal will make the Israeli brain-AI specialist a wholly owned subsidiary.
Transaction terms
The transaction is subject to approvals from relevant Israeli regulatory authorities. Bio Search expects completion between December 2026 and early January 2027. Once completed, InnerEye will operate as a wholly owned Bio Search subsidiary.
Company backgrounds
InnerEye was founded in 2014 in Herzliya, Israel. Its technology stems from research at the Hebrew University and Ben-Gurion University. Bio Search has business development strength in Japan and overseas markets.
Brain-AI integration
InnerEye analyzes EEG signals in real time to identify cognitive states tied to perception and decision-making. Bio Search plans to combine this technology with its biometric sensing and medical device capabilities. The group aims to serve healthcare, industrial automation, security, and decision support markets.
Bio Search and InnerEye also plan to build a global management structure across Japan and Israel. The group targets a NASDAQ listing in 2028. That roadmap depends on completing the acquisition and meeting regulatory conditions.